Recent Updates
Recently added Catalysts
NMTC Positive Sentiment Score: 65/100

NeuroOne to Report Second Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on May 14

Friday, May 10, 2024 2 min read
Key Takeaway: NeuroOne Medical Technologies Corporation will hold a conference call and webcast on May 14, 2024, to discuss its financial results for the second quarter of fiscal year 2024, which ended on March 31, 2024. The company, focused on surgical solutions for neurological disorders, aims to improve patient care and reduce procedural costs. This update aims to inform stakeholders about the company's current status and future direction. NeuroOne's expanding applications indicate a commitment to innovation within the medical technology field.

Market Sentiment Analysis

POSITIVE FACTORS

  • NeuroOne is set to report financial results, indicating growth and transparency.
  • The company is focusing on improving surgical care options for neurological disorders.
  • Potential exploration of additional applications, such as depression and artificial intelligence, could enhance the company's portfolio.

Full Press Release Details

EDEN PRAIRIE, Minn., May 10, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, will host a conference call and webcast on May 14, 2024 at 4:30 PM Eastern Time to discuss financial results for its second quarter of fiscal year 2024 ended March 31, 2024, and provide a corporate update.
Conference Call and Webcast Information:
Tuesday, May 14, 2024 – 4:30 PM Eastern Time
Participant Dial-In:
Toll Free: 888-506-0062
International: 973-528-0011
Toll Free: 877-481-4010
International: 919-882-2331
Replay Passcode: 50624
Available through May 28, 2024
Available for 12 months
NeuroOne Medical Technologies Corporation is a developmental stage company committed to providing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders that may improve patient outcomes and reduce procedural costs. The Company may also pursue applications for other areas such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. For more information, visit nmtc1.com.

Tags

NeuroOne Medical Technologies
2024 Financial Results
Provide Corporate Update
medical technology company

Frequently Asked Questions

What is NeuroOne Medical Technologies focused on?

NeuroOne Medical Technologies focuses on enhancing surgical options and outcomes for neurological disorders.

When will NeuroOne host a conference call?

NeuroOne will host a conference call on May 14, 2024, at 4:30 PM ET.

What phone numbers can I use to join the conference call?

Participants can dial 888-506-0062 for toll-free or 973-528-0011 for international access.

What conditions does NeuroOne address?

NeuroOne addresses epilepsy, Parkinson's disease, chronic pain, and other neurological disorders.

How long will the conference call replay be available?

The replay will be available until May 28, 2024.

Tags: NMTC Viatris Investor Conferences Healthcare NeuroOne medical technology financial results neurological disorders
Last updated: May 10, 2024